The company reported net profit of Rs 102 crore during Q2FY23, compared to Rs 67 crore during the corresponding quarter of the previous year. Revenues rose 26% YoY to Rs 784 crore in Q2FY23 compared to Rs 623 in the year ago period.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/USEIRMB
via IFTTT
0 comments:
Post a Comment